Flk-1 specific kinase inhibitor (SU5416) inhibited the growth of GS-9L glioma in rat brain and prolonged the survival

Kobe Journal of Medical Sciences

Volumn 47, Issue 4, 2001, Pages 181-191

  Takamoto, Takeshi ^a   Sasaki, Masato ^a   Kuno, Takayoshi ^a   Tamaki, Norihiko ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti angiogenic therapy; Flk 1 specific kinase inhibitor; Malignant gliomas; SU5416; VEGF (Vascular endothelial growth factor)

Indexed keywords

ANGIOGENESIS INHIBITOR; PROTEIN TYROSINE KINASE; SEMAXANIB;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOMA; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; RAT; TREATMENT OUTCOME; VASCULARIZATION;

ANIMALS; APOPTOSIS; BRAIN; BRAIN NEOPLASMS; ENZYME INHIBITORS; GLIOMA; INDOLES; MALE; MICROCIRCULATION; PYRROLES; RATS; RATS, INBRED F344; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SURVIVAL RATE;

EID: 0035700915     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Angiogenesis
2. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vasculization and growth of multiple tumor types
3. Inhibition of vascular endothelial cell growth factor activity by an endogeneously encoded soluble receptor
4. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
5. The amgiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function
6. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutants
7. A High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
8. Dominant-negative Inhibition of Flk-1 suppresses the growth of many tumor types in vivo
9. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
10. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
11. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
12. Antitumor activity of anti-Flk-1 monoclonal antibodies
13. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
14. Retrovirus Producer Cells encoding Antisence VEGF prolong survival of rats with intracranial GS-9L Gliomas
15. Cell-type specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
16. Shawver LK: Flk-1 as a target for tumor growth inhibition
17. Synthesis and biological evaluation of 3-substituted indolin-2-ones, a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases
18. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470)
19. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells